Evidence map›Paper›PMID 42121061›Full record

Observational studyBMC nephrology2026

Hematological parameter dynamics in critically ill patients treated with oXiris

Nikolina Špirić, Katarina Vučićević, Jesús Villar, Tijana Kovačević, Saša Dragić, Biljana Zlojuto, Danica Momčičević, Milka Jandrić, Grozdana Klječanin, Pedja Kovačević

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nikolina ŠpirićDepartment of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade, 11000, Republic of Serbia. spiric.nikolina1@gmail.com.ORCID 0009-0008-3704-9189
Katarina VučićevićDepartment of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade, 11000, Republic of Serbia.
Jesús VillarResearch Unit at Hospital Universitario Dr. Negrín, Fundación Canaria Instituto de Investigación Sanitaria de Canarias, Las Palmas, Spain.
Tijana KovačevićClinical Pharmacy Department, University Clinical Centre of the Republic of Srpska, The Republic of Srpska, Bosnia and Herzegovina, Dvanaest Beba bb, Banja Luka, 78000, Bosnia and Herzegovina.
Saša DragićFaculty of Medicine, University of Banja Luka, The Republic of Srpska, Bosnia and Herzegovina, Dvanaest Beba bb, Banja Luka, 78000, Bosnia and Herzegovina.
Biljana ZlojutoFaculty of Medicine, University of Banja Luka, The Republic of Srpska, Bosnia and Herzegovina, Dvanaest Beba bb, Banja Luka, 78000, Bosnia and Herzegovina.
Danica MomčičevićFaculty of Medicine, University of Banja Luka, The Republic of Srpska, Bosnia and Herzegovina, Dvanaest Beba bb, Banja Luka, 78000, Bosnia and Herzegovina.
Milka JandrićFaculty of Medicine, University of Banja Luka, The Republic of Srpska, Bosnia and Herzegovina, Dvanaest Beba bb, Banja Luka, 78000, Bosnia and Herzegovina.
Grozdana KlječaninMedical Intensive Care Unit, University Clinical Centre of the Republic of Srpska, The Republic of Srpska, Banja Luka, Bosnia and Herzegovina.
Pedja KovačevićFaculty of Medicine, University of Banja Luka, The Republic of Srpska, Bosnia and Herzegovina, Dvanaest Beba bb, Banja Luka, 78000, Bosnia and Herzegovina. pedja.kovacevic@med.unibl.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHemoadsorption is increasingly used as adjunctive extracorporeal support in sepsis and septic shock. Comparative data on device-specific hematologic effects remain limited. CytoSorb

methodsIn a prospective single-center observational study, 66 patients with sepsis or septic shock underwent hemoadsorption combined with continuous renal replacement therapy (CRRT) using either CytoSorb

resultsCytoSorb

conclusionCytoSorb

Indexed as

Continuous Renal Replacement TherapyCritical IllnessSepsisShock, SepticAgedFemaleHematocritHemoglobinsHumansMaleMiddle AgedProspective StudiesHemoglobinsHematologic deteriorationHemoadsorptionHemoadsorption devicesSepsisSeptic shock

Identifiers

PMID42121061
PMCPMC13340367

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.